Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Genomain AB
AB
Active
Org 5594884446
Pumpgatan 1, 417 55
Göteborg
Business and other management consultancy activities
·
NACE 7020
Est. 2024 · 2 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Genomain AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
1M
2025
EBITDA
SEK millions
0M
0M
-1M
-1M
-1M
-1M
2025
Income statement
SEK thousands
Item
2025
Revenue
634
Staff expenses
−1 393
EBITDA
−1 183
Depreciation & amort.
−54
EBIT
−1 238
Net financials
−35
Profit before tax
−1 273
Tax
—
Net profit
−1 273
Balance sheet
SEK thousands
Item
2025
Total assets
1 933
Equity
27
Long-term debt
1 125
Short-term debt
781
Total debt
1 906
Financial ratios
5-year trend
EBITDA margin
-186.6%
This company
15.8%
Market median
1281% below market
2025
2025
Equity ratio
1.4%
This company
38.2%
Market median
96% below market
2025
2025
Return on equity
-4767.5%
This company
18.4%
Market median
26010% below market
2025
2025
Net profit margin
-200.8%
This company
8.1%
Market median
2579% below market
2025
2025
Asset turnover
0.33×
This company
1.12×
Market median
71% below market
2025
2025
Debt / equity
71.36×
This company
0.62×
Market median
11410% above market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-12-31
View
PDF
More on Genomain AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
